Sorrento Therapeutics
UEI: KWEWLHZ59FL3
• CAGE: 5SPZ9
Overview
Parent Awardee
Name
Sorrento Therapeutics
Headquarters
San Diego, CA
United States
United States
Most Recent Award
June 1, 2023
Calculating
Federal contract and grant recipient
SORRENTO THERAPEUTICS, INC.
(UEI KWEWLHZ59FL3, CAGE 5SPZ9)
is headquartered in San Diego CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in January 2006 and
federally registered in
November 2009.
Federal Award Analysis
Sorrento Therapeutics federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
SORRENTO THERAPEUTICS, INC.
UEI
KWEWLHZ59FL3
CAGE Code
5SPZ9
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 25, 2006
Initial Registration
Nov. 18, 2009
Last Registration
Aug. 21, 2024
Registration Activation
Aug. 21, 2024
Registration Expiration
Aug. 19, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Disaster Registry
Nationwide
Accepts Credit Cards
No